Halozyme Therapeutics Valuation Percentage
Halozyme Therapeutics Valuation Percentage Chart
Halozyme Therapeutics Historical Valuation Percentage DataPro Data Export
There is no data for the selected date range.
About Valuation Percentage
Click the "Learn More" link below to see how the valuation percentage is calculated.
The valuation percentage shows how far above or below its historical valuation levels the stock currently is. It takes into account a long-term average of the Price to Sales Ratio and Price to Earnings Ratio and mathematically determines whether the current price is high or low relative to those historic valuation multiples.
It is important to note that this is not a measurement of how the stock's price relates to its "intrinsic value", but is instead a measurement of how the market is valuing the stock relative to how it was valued historically.
View Valuation Percentage for HALO.
Start Your YCharts Pro Gold Membership.
Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
YCharts Pro is only $49/month, and comes with a 14-day free trial.Get Started Now
Already a YCharts Pro Gold Member? Sign in here.
HALO Valuation Percentage Benchmarks
|Infinity Pharmaceuticals||Go Pro|
HALO Valuation Percentage Range, Past 5 Years
|Minimum||Go Pro||Dec 2010|
|Maximum||Go Pro||Dec 2011|
Fool May 23
Street Insider May 23
PR Newswire May 23
Business Wire May 21